Xenon Pharmaceuticals Inc. | Mutual Funds
Mutual Funds that own Xenon Pharmaceuticals Inc.
American Funds Small Cap World Fund
1,429,000
7.42%
0
0.05%
06/30/2018
Tekla Life Sciences Investors
233,331
1.21%
0
0.64%
12/31/2017
FCP OP Medical BioHe@lth-Trends
96,321
0.5%
0
0.73%
11/30/2017
93,335
0.49%
-23,334
0.18%
03/31/2018
APO Medical Opportunities
62,875
0.33%
-19,194
0.16%
03/31/2018
Pharma/wHealth Fund
17,693
0.09%
0
0.17%
11/30/2017
APO Medical Opportunities Institutionell
13,983
0.07%
0
0.09%
06/29/2018
DFA US Core Equity 2 Portfolio
11,120
0.06%
0
0%
04/30/2018
Fidelity Nasdaq Composite Index
7,695
0.04%
0
0%
07/31/2018
RIM Global - CC Bioscience
7,000
0.04%
7,000
0.67%
06/30/2017
| Address |
3650 Gilmore Way
Burnaby British Columbia V5G 4W8
Canada
|
|
Employees
|
- |
| Website |
http://www.xenon-pharma.com |
| Updated |
07/08/2019 |
| Xenon Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in discovering and developing a pipeline of differentiated therapeutics. It has built a core enabling discovery platform for the discovery of validated drug targets by studying rare human diseases with extreme traits, including diseases caused by mutations in ion channels, known as channelopathies. |
